Natalizumab therapy, 2013 [PDF]
, 2014 Multiple sclerosis (MS) is the most common chronic disease of the central nervous system in young adults. No curative therapy is known. Currently, six drugs are available that can reduce the activity of MS.
Bencsik, Krisztina +2 more
core
A Representative Survey of M.S. Patients on Attitudes toward the Benefits and Risks of Drug Therapy [PDF]
Background: Although M.S. patients face significant trade-offs between risks and benefits of drug therapy, little is known of their attitudes toward these risks and benefits.
Calfee, John E.
core +1 more source
Safety monitoring of the newer disease modifying therapies in multiple sclerosis patients in Mater Dei hospital [PDF]
, 2016 Patients with highly active Multiple Sclerosis can be started on the newer pharmaceutical agents, Dimethyl Fumarate or Fingolimod. Safety monitoring recommended includes regular blood analysis and also ophthalmic tests and MRI scans in the case of ...
Aquilina, Josanne, Zammit, Daniela
core
Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort Study [PDF]
, 2017 Background. We investigated the incidence and outcome of progressive multifocal leukoencephalopathy (PML) in human immunodeficiency virus (HIV)-infected individuals before and after the introduction of combination antiretroviral therapy (cART) in 1996 ...
Battegay, Manuel +9 more
core
Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies [PDF]
, 2015 Multiple sclerosis is a demyelinating disease affecting the central nervous system. It is the most prevalent disabling neurological condition among young adults, with onset typically between 20 and 40 years of age. Infiltrating immune cells and microglia
Kay, Kathleen Alexandra
core +1 more source
Posterior fossa tremor induced by HIV-associated progressive multifocal leukoencephalopathy [PDF]
, 2005 Asmus, F. +4 more
core +1 more source
spectrum of acquired demyelinating disorders of the central nervous system in adults in a tertiary care hospital [PDF]
, 2014 Acquired demyelinating disorders of the central nervous system are diverse group of conditions characterized by destruction or disturbance of myelin sheath in the central nervous system i.e. brain and spinal cord.
Alam, Dr Naveed +3 more
core +1 more source
New and Old Concepts and Strategies for Progressive Multifocal Leukoencephalopathy [PDF]
, 2014 Monica Marta, IM
core +1 more source
[Progressive multifocal leukoencephalopathy].
Vojnosanitetski pregled, 1998 Progressive multifocal leukoencephalopathy (PML) is rare and very severe disease, classified into the group of subacute and viral infections of central nervous system (CNS), and can simulate clinical pictures of numerous degenerative diseases of nervous system.
R, Raicević +4 more
openaire +1 more source
Progressive multifocal leukoencephalopathy - a diagnostic guide for the clinical neurologist. [PDF]
Front NeurolJia DT.
europepmc +1 more source